Silybin and metabolic disorders

Affiliations

¹ Department of Internal Medicine and Medical Specialties, I Clinica Medica, Atherothrombosis Centre, Sapienza University of Rome, Viale del Policlinico 155, 00161, Rome, Italy. pasquale.pignatelli@uniroma1.it.
² Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.
³ Department of Internal Medicine and Medical Specialties, I Clinica Medica, Atherothrombosis Centre, Sapienza University of Rome, Viale del Policlinico 155, 00161, Rome, Italy.

Comment

Pasquale Pignatelli et al. Intern Emerg Med. 2019 Jan.

. 2019 Jan;14(1):1-3.

doi: 10.1007/s11739-018-1968-x. Epub 2018 Oct 17.

¹ Department of Internal Medicine and Medical Specialties, I Clinica Medica, Atherothrombosis Centre, Sapienza University of Rome, Viale del Policlinico 155, 00161, Rome, Italy. pasquale.pignatelli@uniroma1.it.
² Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.
³ Department of Internal Medicine and Medical Specialties, I Clinica Medica, Atherothrombosis Centre, Sapienza University of Rome, Viale del Policlinico 155, 00161, Rome, Italy.

No abstract available

Comment on

Metabolic and vascular effects of silybin in hypertensive patients with high 1-h post-load plasma glucose.
Sciacqua A, Perticone M, Tripepi G, Addesi D, Cassano V, Maio R, Sesti G, Perticone F. Sciacqua A, et al. Intern Emerg Med. 2019 Jan;14(1):77-84. doi: 10.1007/s11739-018-1951-6. Epub 2018 Sep 19. Intern Emerg Med. 2019. PMID: 30232738